GEODE CAPITAL MANAGEMENT, LLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 55 filers reported holding ENZO BIOCHEM INC in Q2 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$473,139
-23.8%
337,856
+0.1%
0.00%
Q2 2023$621,138
-28.0%
337,575
-4.9%
0.00%
Q1 2023$862,752
+171081.0%
355,042
+0.6%
0.00%
Q4 2022$504
-99.9%
352,848
-1.3%
0.00%
Q3 2022$797,000
+8.0%
357,544
+0.3%
0.00%
Q2 2022$738,000
-27.2%
356,567
+1.9%
0.00%
Q1 2022$1,014,000
-8.8%
349,821
+1.0%
0.00%
Q4 2021$1,112,000
-9.3%
346,4850.0%0.00%
Q3 2021$1,226,000
+10.7%
346,485
-0.8%
0.00%
Q2 2021$1,107,000
-51.2%
349,221
-47.1%
0.00%
Q1 2021$2,270,000
+50.4%
660,025
+10.2%
0.00%
Q4 2020$1,509,000
+21.8%
599,196
+2.0%
0.00%
Q3 2020$1,239,000
-3.8%
587,482
+2.2%
0.00%
Q2 2020$1,288,000
-9.0%
575,005
+2.7%
0.00%
Q1 2020$1,416,000
-47.6%
559,743
-45.5%
0.00%
Q4 2019$2,702,000
+46.9%
1,027,584
+101.1%
0.00%
Q3 2019$1,839,000
+13.2%
510,865
+5.9%
0.00%
Q2 2019$1,624,000
+39.9%
482,181
+13.4%
0.00%
Q1 2019$1,161,000
-49.2%
425,306
-48.3%
0.00%
Q4 2018$2,284,000
+17.3%
822,276
+73.9%
0.00%
-100.0%
Q3 2018$1,947,000
-17.5%
472,819
+3.9%
0.00%0.0%
Q2 2018$2,361,000
+7.5%
455,183
+13.5%
0.00%0.0%
Q1 2018$2,196,000
-19.7%
400,938
+19.4%
0.00%0.0%
Q4 2017$2,736,000
-21.3%
335,820
+1.1%
0.00%0.0%
Q3 2017$3,477,000
-5.5%
332,135
-0.4%
0.00%0.0%
Q2 2017$3,678,000
+51.0%
333,302
+14.5%
0.00%0.0%
Q1 2017$2,436,000
+31.0%
291,119
+8.6%
0.00%0.0%
Q4 2016$1,860,000
+40.0%
268,083
+2.7%
0.00%0.0%
Q3 2016$1,329,000
-23.2%
261,118
-10.0%
0.00%0.0%
Q2 2016$1,730,000
+110.5%
289,986
+60.4%
0.00%
Q1 2016$822,000
+4.2%
180,845
+3.0%
0.00%
Q4 2015$789,000
+41.9%
175,5360.0%0.00%
Q3 2015$556,000
+16.3%
175,536
+11.2%
0.00%
Q2 2015$478,000
-13.1%
157,821
-15.4%
0.00%
Q1 2015$550,000
-30.8%
186,603
+4.0%
0.00%
Q4 2014$795,000
-12.0%
179,353
+2.2%
0.00%
-100.0%
Q3 2014$903,000
-1.0%
175,563
+1.1%
0.00%0.0%
Q2 2014$912,000
+47.1%
173,734
+16.4%
0.00%
Q1 2014$620,000
+146.0%
149,250
+72.3%
0.00%
Q4 2013$252,000
+15.6%
86,6280.0%0.00%
Q3 2013$218,000
+21.1%
86,6280.0%0.00%
Q2 2013$180,00086,6280.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q2 2022
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders